The catalytic active site is the β‐subunit of the F1 portion, which is encoded by ATP synthase β‐subunit (ATP5B) and has been suggested as a potential gastric cancer marker and a new target for paraganglioma [166, 167, 168, 169]. This evidence concerns the gene ATP5F1B and gastric cancer.